Guillain –Barré syndrome after COVID‐19 vaccination with suspected concurrent cytomegalovirus reactivation
ConclusionsThe present case suggests that cytomegalovirus reactivation might play a role in the pathogenesis of GBS associated with COVID-19 vaccination. Accounting for cytomegalovirus reactivation might reveal unidentified pathophysiology of GBS after COVID-19 vaccination.
Source: Clinical and Experimental Neuroimmunology - Category: Neurology Authors: Katsuhiro Itogawa,
So Okubo,
Minako Yamada,
Taro Bannai,
Tomonari Seki,
Ayumi Uchibori,
Yasushi Shiio Tags: CASE REPORT Source Type: research
More News: Brain | Coronavirus | Covid Vaccine | COVID-19 | Cytomegalovirus | Guillain-Barr Syndrome | Neurology | Pandemics | Study | Vaccines